Ivacaftor
Showing 176 - 197 of 197
Cystic Fibrosis Trial (ivacaftor, VX-661, ciprofloxacin)
Completed
- Cystic Fibrosis
- ivacaftor
- +2 more
- (no location specified)
Mar 25, 2014
Cystic Fibrosis Trial in Charlottesville (VX-770, Placebo)
Hepatic Impairment, Healthy Trial in Praha, Bratislava (lumacaftor 200 mg q12h + ivacaftor 250 mg q12h)
Completed
- Hepatic Impairment
- Healthy
- lumacaftor 200 mg q12h + ivacaftor 250 mg q12h
-
Praha, Czech Republic
- +1 more
Nov 18, 2013
Long Term Significance (Survival) of LCI in Cystic Fibrosis
Withdrawn
- Cystic Fibrosis (CF)
- EasyOne Pro and Ecomedics
-
Woluwé-Saint-Lambert, Bruxelles, BelgiumCliniques Universitaires Saint-Luc (UCL)
Jan 14, 2015
Cystic Fibrosis Trial in Canada, Germany, United States (Ivacaftor 25 mg/75 mg, Ivacaftor 75 mg/150 mg, Ivacaftor 150 mg or 250
Completed
- Cystic Fibrosis
- Ivacaftor 25 mg/75 mg
- +3 more
-
Birmingham, Alabama
- +14 more
Oct 3, 2012
In Development for Cystic Fibrosis Trial in Hradec Králové, Praha, Bratislava (VX-770)
Completed
- In Development for Cystic Fibrosis
-
Hradec Králové, Czech Republic
- +2 more
Jan 11, 2011
In Development for Cystic Fibrosis Trial in Daytona Beach (VX-770)
Completed
- In Development for Cystic Fibrosis
-
Daytona Beach, FloridaCovance CRU, Inc.
Dec 8, 2010